about
Functional changes in pulmonary arterial endothelial cells associated with BMPR2 mutationsRecent progress in understanding pediatric pulmonary hypertensionMicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial HypertensionThree-dimensional micro computed tomography analysis of the lung vasculature and differential adipose proteomics in the Sugen/hypoxia rat model of pulmonary arterial hypertensionEtiopathogenetic mechanisms of pulmonary hypertension in sleep-related breathing disorders.A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.Pulmonary hypertension's variegated landscape: a snapshot.Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.Pulmonary hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.Pulmonary vascular stiffness: measurement, modeling, and implications in normal and hypertensive pulmonary circulationsSaudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updatesAngiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats.Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analysesIL-10R blockade during chronic schistosomiasis mansoni results in the loss of B cells from the liver and the development of severe pulmonary disease.Pulmonary arterial hypertension in Saudi Arabia: Patients' clinical and physiological characteristics and hemodynamic parameters. A single center experience.Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertensionSerotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH.Left ventricular dysfunction in patients with suspected pulmonary arterial hypertension.Molecular physiopathogenetic mechanisms and development of new potential therapeutic strategies in persistent pulmonary hypertension of the newbornUnrecognized glucose intolerance is common in pulmonary arterial hypertensionDiagnosis and management of pulmonary arterial hypertensionThe genetics of pulmonary arterial hypertension in the post-BMPR2 era.Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling.Disruption of miR-29 Leads to Aberrant Differentiation of Smooth Muscle Cells Selectively Associated with Distal Lung Vasculature.Differences of cardiac output measurements by open-circuit acetylene uptake in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a cohort study.Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats.Interplay of macrophages and T cells in the lung vasculature.Obstructive sleep apnea and cardiovascular comorbidities: a large epidemiologic study.A novel molecular signature for elevated tricuspid regurgitation velocity in sickle cell disease.Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension.Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats.Salidroside exerts protective effects against chronic hypoxia-induced pulmonary arterial hypertension via AMPKα1-dependent pathways.Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injuryPlasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension.High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.Nitric oxide deficiency in pulmonary hypertension: Pathobiology and implications for therapy.Nerve distribution of canine pulmonary arteries and potential clinical implications.Gender, sex hormones and pulmonary hypertension.Schistosomiasis causes remodeling of pulmonary vessels in the lung in a heterogeneous localized manner: Detailed study.
P2860
Q24303490-2CAB8230-44A1-45E3-A604-17038A836B83Q27691453-11DD6797-E50F-4AFD-B24B-5958C59AB2CDQ28114802-D2735EB3-0DBF-4E1E-B124-C9F36B4DD200Q28359603-75CED292-5553-42C0-887F-00106E416794Q30419870-A6C8833A-41AE-4672-B000-DE69B8086C68Q30544892-8ECA30AB-1F2C-4E27-B85B-70DCA05C45C5Q33738561-00CC623D-024D-4021-AE68-3A51665F750EQ33803027-1B6AE3BC-1B4E-49B5-96A9-212A01B91777Q33956819-B3070168-9C30-4CC2-848A-DF43B45306CDQ33961625-13C20356-F5ED-46C8-A35A-28456E3DBB8FQ33965904-FE84AFBA-3D7C-4609-989A-2401212D267BQ34001678-5CB96249-C6DA-4773-88B0-49AF31C3792FQ34095714-DA3177D4-2110-4343-8245-3AB5FF8C49E6Q34145683-5CBD7B6E-10BB-481C-86A1-FA9343B0D5D1Q34197167-9408E4AF-9A47-4072-9F10-E80ADECD2614Q34840778-29F23F07-54E2-4D38-931E-7BF4A9CECD94Q34973575-FB0FFA43-D758-4CC0-9AA6-42797913B1F4Q34993093-A2083603-9F30-40D8-B262-FC041B1F35ECQ35084278-43B54DB1-B726-4680-9C5C-9E03E198713CQ35085796-9275882F-1A69-4645-A470-BAF5522A403DQ35222937-018A5126-62DD-40E4-8F57-B04FD52B9B94Q35573919-6D1B2914-1DB7-498E-8B9D-D1E2EF97FDFBQ35601455-86065A20-5DB6-4C1F-8924-FA41F2707A0DQ35644474-45B4AD9E-091B-428A-96B7-79F554078DF1Q35881203-2E2114D3-9D3A-49B2-A606-6F6160F28A3FQ35950168-F31A96D9-9F4F-45EA-B948-393B306654C7Q35994814-E80FDDD2-E36A-4DC0-99C0-93802A28C023Q36150776-AF14E2B4-6A5B-4B0F-AA9B-975B75536DC9Q36238248-3A2C9491-0674-408D-A807-79AB8F32BA16Q36447357-F8C80629-D138-4240-ABE7-3C1D57512E82Q36535430-0B7A8649-56EE-4642-A52A-25420BFB3CC2Q36595077-A4122F57-4B55-4D65-A118-0AEFAA99B730Q36595381-562E9341-0735-4734-98A0-5A3E56AEB7DFQ36601764-79CF448C-067B-4662-849D-7980828D7E64Q36621780-3E039F71-47A5-488E-AA8C-DFD6B2174630Q36795578-1F5F172A-2775-40D1-971B-683004145FC5Q36810804-A58DECFF-0A8D-4369-930A-653ED571A2F5Q36841106-B1E5D095-CD96-4850-BBC0-452F0E96CC66Q37133789-4C4C472C-BCF4-448F-982C-EAB82E619240Q37133810-243EE035-FFF1-4E47-92AD-CA6D81E346EE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development and pathology of pulmonary hypertension.
@en
Development and pathology of pulmonary hypertension.
@nl
type
label
Development and pathology of pulmonary hypertension.
@en
Development and pathology of pulmonary hypertension.
@nl
prefLabel
Development and pathology of pulmonary hypertension.
@en
Development and pathology of pulmonary hypertension.
@nl
P2093
P1476
Development and pathology of pulmonary hypertension
@en
P2093
Frédérique Capron
Patricia A Thistlethwaite
Rubin M Tuder
Sheila G Haworth
Steven H Abman
Troy Stevens
P356
10.1016/J.JACC.2009.04.009
P407
P433
P50
P577
2009-06-01T00:00:00Z